This study indicates that flavivirus-naïve participants who received the dengue vaccine did not demonstrate enhancement of infection in Vero-CD32a cells against any of the four DENV serotypes even after 10-years post-vaccination [28]. The gene discussed is FCGR2A; the disease is infection.